Assists SANUWAVE with Successful De Novo Clearance by FDA

MCRA Assists SANUWAVE with Successful De Novo Decision: 3rd Wound Care De Novo Since 2010

WASHINGTON, Jan. 10, 2018 /PRNewswire-USNewswire/ — Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) has announced its role in the successful de novo clearance by the U.S.…